Nomic Bio · Jun 2026
Nomic announced a collaboration with HESI Global’s OASIS Consortium to profile more than 3,000 HepaRG cell samples and build proteomic training data for predictive toxicity models.
Nomic is doing for proteins what Illumina has done for DNA
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Nomic Bio is a Montreal-based biotechnology company focused on industrial-scale proteomics and protein profiling through its proprietary nELISA platform, with productized offerings such as Omni 1000, Core, Flex, and an end-to-end profiling service.
Primary product
nELISA proteomics platform (flagship Omni 1000 assay)
Founded
2017
Headquarters
Montreal, Quebec, Canada
Team size
80-90
Work style
Flexible
Industry
Biotechnology Research
Sub-industry
Proteomics / protein profiling
Offices
Open Positions
5 jobs at Nomic Bio
Senior Scientist - Manufacturing Development
On-siteOperationsMontreal3w ago
On-site